TRIPROLIDINE AND PSEUDOEPHEDRINE Drug Patent Profile

Which patents cover Triprolidine And Pseudoephedrine, and when can generic versions of Triprolidine And Pseudoephedrine launch?

Triprolidine And Pseudoephedrine is a drug marketed by Watson Labs, West Ward, Kv Pharm, and Cenci. and is included in five NDAs.

The generic ingredient in TRIPROLIDINE AND PSEUDOEPHEDRINE is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

Summary for TRIPROLIDINE AND PSEUDOEPHEDRINE

US Patents:	0
Applicants:	4
NDAs:	5
Raw Ingredient (Bulk) Api Vendors:	6
Patent Applications:	9
DailyMed Link:	TRIPROLIDINE AND PSEUDOEPHEDRINE at DailyMed

US Patents and Regulatory Information for TRIPROLIDINE AND PSEUDOEPHEDRINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	TRIPROLIDINE AND PSEUDOEPHEDRINE	pseudoephedrine hydrochloride; triprolidine hydrochloride	TABLET;ORAL	088318-002	Jan 13, 1984		DISCN	No	No
Kv Pharm	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES	pseudoephedrine hydrochloride; triprolidine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	072758-001	Nov 25, 1991		DISCN	No	No
West Ward	TRIPROLIDINE AND PSEUDOEPHEDRINE	pseudoephedrine hydrochloride; triprolidine hydrochloride	TABLET;ORAL	088117-001	Apr 19, 1983		DISCN	No	No
Kv Pharm	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES	pseudoephedrine hydrochloride; triprolidine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	071798-001	Mar 16, 1989		DISCN	No	No
Cenci	TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE	codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride	SYRUP;ORAL	089018-001	Jul 23, 1986		DISCN	No	No